Showing results (271-280 of 300) with videos related to

Sort By:
Pageof 30
Surgery|June 8, 2001
Real-time assessment of intraperitoneal tumor growth in a rat model using CEA immunoscintigraphyM Pross, H U Schulz, T Günther, et al.
Cancer Research|April 15, 2000
Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancerM P Ebert, T Günther, J Hoffmann, et al.
Der Anaesthesist|November 12, 2010
[Caspofungin after solid organ transplantation in Germany: observational study on treatment of invasive fungal infections]C Lichtenstern, J Pratschke, U Schulz, et al.
European Journal of Gastroenterology & Hepatology|January 23, 1999
Analysis of K-ras gene mutations in rare pancreatic and ampullary tumoursM P Ebert, J Hoffmann, R Schneider-Stock, et al.
Zentralblatt Fur Gynakologie|May 5, 2006
[Stereotactic body radiotherapy (SBRT) -- an overview under special consideration of SBRT and LITT in the therapy of liver metastases]I Ernst, P S Lücking, F Eickmeyer, et al.
European Journal of Human Genetics : EJHG|October 22, 1998
Evidence against a major role of PEG1/MEST in Silver-Russell syndromeA M Riesewijk, N Blagitko, A A Schinzel, et al.
The Thoracic and Cardiovascular Surgeon|August 12, 2006
The controversy of donor serum sodium levels in heart transplantation--a multicenter experienceI Kaczmarek, G Tenderich, J Groetzner, et al.
The Heart Surgery Forum|June 29, 2007
Cardiac surgery after heart transplantation: coronary artery bypass grafting and heart valve replacementK O Coskun, S T Coskun, M El Arousy, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2022
Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of lifeThomas U Schulz, Sarah Zierold, Michael M Sachse, et al.
Data in Brief|November 25, 2022
Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseasesThomas U Schulz, Sarah Zierold, Michael M Sachse, et al.
Pageof 30